Mary Kerr
Vorstandsvorsitzender bei NeRRe Therapeutics Ltd.
Aktive Positionen von Mary Kerr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.09.2015 | - |
Vorstandsvorsitzender | 01.09.2015 | - | |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Direktor/Vorstandsmitglied | 08.09.2017 | - |
Karriereverlauf von Mary Kerr
Ehemalige bekannte Positionen von Mary Kerr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GALAPAGOS NV | Direktor/Vorstandsmitglied | 26.07.2016 | 18.09.2023 |
Independent Dir/Board Member | 26.07.2016 | 18.09.2023 | |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2017 | 01.09.2020 |
Vorstandsvorsitzender | 01.01.2017 | 01.09.2020 | |
Gründer | 01.01.2017 | 01.09.2020 | |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - | - |
Global Franchise Group LLC
Global Franchise Group LLC Food RetailRetail Trade Global Franchise Group LLC operates as a strategic brand management company with a focus on franchising. It specializes in franchising restaurant industries. The company was founded in 2010 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | - | - |
Ausbildung von Mary Kerr
University of Bradford | Doctorate Degree |
Kingston University | Masters Business Admin |
Statistik
International
Vereinigtes Königreich | 7 |
Belgien | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GALAPAGOS NV | Health Technology |
Private Unternehmen | 5 |
---|---|
Global Franchise Group LLC
Global Franchise Group LLC Food RetailRetail Trade Global Franchise Group LLC operates as a strategic brand management company with a focus on franchising. It specializes in franchising restaurant industries. The company was founded in 2010 and is headquartered in Atlanta, GA. | Retail Trade |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Distribution Services |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Commercial Services |